Home
Conditions
Pulmonary Arterial Hypertension (PAH) (WHO Group 1 PH)

Clinical trial condition

Pulmonary Arterial Hypertension (PAH) (WHO Group 1 PH)

Explore clinical trials studying Pulmonary Arterial Hypertension (PAH) (WHO Group 1 PH). Study availability and eligibility vary by location and protocol.

10 public trials 6 recruiting studies

Refine in advanced search Browse all conditions

Pulmonary Arterial Hypertension (PAH) (WHO Group 1 PH) trial results

Recruiting

Nailfold Capillaroscopy in PH

NCT07768644

Conditions: Cardiovascular Diseases, Chronic Thromboembolic Pulmonary Hypertension, Hypertension, +7 more
Locations: NHS Golden Jubilee Clydebank, West Dunbartonshire, United Kingdom

View Trial Details

Recruiting

The Impact of ERA Switching on Risk Stratification in Pulmonary Arterial Hypertension

NCT07013149

Conditions: Hypertension, Pulmonary, Lung Diseases, Pulmonary Arterial Hypertension, +3 more
Locations: InCor - FMUSP São Paulo, Brazil

View Trial Details

Recruiting

Validation of a Patient Knowledge Questionnaire for Pulmonary Hypertension

NCT07120789

Conditions: Adherence Interventions, Behavior, Cardiovascular Diseases, +19 more
Locations: Instituto do Coração (InCor), Hospital das Clínicas HCFMUSP, Faculdade de Medicina, Universidade de São Paulo São Paulo, Brazil

View Trial Details

Recruiting

Rutgers University Study of the Genetics of Pulmonary Hypertension

NCT07217522

Conditions: Cardiovascular Diseases, Hypertension, Hypertension, Pulmonary, +11 more
Locations: Rutgers University, Piscataway, New Jersey 08854 Piscataway, New Jersey, United States

View Trial Details

Recruiting

PulmonAry hyperteNsion DiagnOsis: a National cohoRt reseArch

NCT06998329

Conditions: Cardiovascular Diseases, Disease, Hypertension, +9 more
Locations: InCor - Universidade de São Paulo São Paulo, Brazil

View Trial Details

Recruiting

imprOving Adherence to Pulmonary artErial hyperteNsion Treatment With teLemedicIne and patieNt guidaNce

NCT06850792

Conditions: Behavior, Health Behavior, Hypertension, Pulmonary, +9 more
Locations: InCor - Universidade de São Paulo São Paulo, Brazil

View Trial Details

Not yet recruiting

A Phase 3 Study of Extended-release Tacrolimus in Subjects With Pulmonary Arterial Hypertension and Functional Limitations

NCT07612657

Conditions: Hypertension, Pulmonary, Lung Diseases, Pulmonary Arterial Hypertension, +5 more
Locations: Not specified

View Trial Details

Completed

Clinical Study to Compare the Efficacy and Safety of Macitentan and Tadalafil Monotherapies With the Corresponding Fixed-dose Combination Therapy in Subjects With Pulmonary Arterial Hypertension (PAH)

NCT03904693

Conditions: Hypertension, Pulmonary, Lung Diseases, Pulmonary Arterial Hypertension, +2 more
Locations: Providence Medical Foundation Fullerton, California, United States

University of Southern California Los Angeles, California, United States

Piedmont Healthcare Atlanta, Georgia, United States

WellStar Health System Marietta, Georgia, United States

View all 148 locations

View Trial Details

Completed

Incorporating the Venous Excess Ultrasound Score (VExUS Score) Into Contemporary Haemodynamic Risk Assessment in Pulmonary Arterial Hypertension: The INVEXUS-PAH Study

NCT07266012

Conditions: Cardiovascular Diseases, Hyperemia, Hypertension, Pulmonary, +6 more
Locations: Istanbul University-Cerrahpasa Institute of Cardiology Istanbul, FATIH, Turkey (Türkiye)

View Trial Details

Completed

The Effect of Slow-Paced Breathing on Patient Outcomes in Pulmonary Arterial Hypertension

NCT07232368

Conditions: Hypertension, Pulmonary, Lung Diseases, Pulmonary Arterial Hypertension, +2 more
Locations: Ege Üniversitesi Izmir, Bornova, Turkey (Türkiye)

View Trial Details

Pulmonary Arterial Hypertension (PAH) (WHO Group 1 PH)

Pulmonary Arterial Hypertension (PAH) (WHO Group 1 PH) trial results

Related conditions